Alfuzosin ((R,S)-N-methylamino propyl" target="_blank" >* tetrahydro-2-furancarboxamide, provided as the hydrochloride salt) is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.
Alfuzosin is marketed by Sanofi Aventis under the brand name Uroxatral®.

Uroxatral - Consumer information from the FDA.